A Northwestern Medicine study has identified new genetic mutations in patients with Wilms tumor, the most common kidney tumor in children.
In several recent publications, Ali Shilatifard, PhD, chair of Biochemistry and Molecular Genetics, examined how different aspects of transcriptional regulation are involved in cancer development.
Carol A. Rosenberg, ’80 MD, has more than three decades’ experience as an internist, clinical researcher and medical educator, but it was an unexpected medical crisis within her own family that profoundly changed the course of her career.
A Northwestern Medicine study unearthed the mechanisms behind arsenic’s anti-cancer effects to show how the chemical compound could combat multiple types of leukemia.
Northwestern Medicine scientists have discovered a new potential drug therapy for pediatric brainstem glioma by targeting a genetic mutation found in patients with the rare, incurable cancer.
Inhibiting a ubiquitin ligase stops tumor growth during hypoxia, a common characteristic of lung and brain cancers.
Leonidas Platanias, MD, PhD, has been appointed director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, a position he has served in interim since January.
Northwestern Medicine scientists have found a new method to measure how patients with breast cancer liver metastasis respond to treatment.
Mary J.C. Hendrix, PhD, revealed a variance in signaling pathways in embryonic stem cells and metastatic melanoma cells that may impact new therapeutic strategies in cancer.
Northwestern Medicine scientists identified a previously unknown signaling pathway that enhances tumor growth in glioblastomas and head and neck cancers. The proteins in the pathway could be targeted in the treatment of human cancers.